Post bone marrow transplant lymphoprolif disorder
Post bone marrow transplant lymphoproliferative disorder
Post heart transplant lymphoproliferative disorder
Post intestine transplant lymphoprolif disorder
Post intestine transplant lymphoproliferative disorder
Post kidney transplant lymphoproliferative disord
Post kidney transplant lymphoproliferative disorder
Post liver transplant lymphoproliferative disorder
Post lung transplant lymphoproliferative disorder
Post pancreas transplant lymphoprolif disorder
Post pancreas transplant lymphoproliferative disorder
Post transplant lymphoproliferative disorder
A condition in which a group of b-cells grow out of control after an organ transplant in patients with weakened immune systems. This usually happens if the patient has also been infected with epstein-barr virus. Post-transplant lymphoproliferative disorder may progress to non-hodgkin lymphoma.
Post-transplant lymphoproliferative disorder ptld) is a polyclonal benign) or clonal malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. Ptlds comprise a spectrum ranging from early, epstein-barr virus ebv)-driven polyclonal lymphoid proliferations to ebv-positive or ebv- negative lymphomas of predominantly b-cell or less often t-cell type. who, 2001)
D47.Z1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM D47.Z1 became effective on October 1, 2022.
This is the American ICD-10-CM version of D47.Z1 – other international versions of ICD-10 D47.Z1 may differ.